Skip to content

US & HILT Comparative Effect on Neuropathic Pain, Strength & QOF in Diabetic Foot

Comparative Effects of Therapeutic Ultrasound and High Intensity Laser Therapy on Neuropathic Pain ,Strength and Quality of Life in Diabetic Foot

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06479577
Enrollment
46
Registered
2024-06-28
Start date
2024-02-01
Completion date
2024-07-01
Last updated
2024-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot, Diabetic Neuropathies

Keywords

diabetic neuropathies

Brief summary

To compare the effects of therapeutic ultrasound and high intensity laser therapy on neuropathic pain , strength and quality of life in patients with diabetic foot

Detailed description

therapeutic ultrasound and laser therapy with routine physical therapy are used to improve neuropathic pain and foot related quality of life. the scarcity of evidence regarding the application of high intensity laser therapy necessitates a comprehensive investigation. The effects of HILT and comparative effects with ultrasound remains largely unexplored in diabetic peripheral neuropathy

Interventions

OTHERultrasound

ultrasound 1 MHZ continuous for 20 minute with routine physical therapy 3 days /week 150 minutes/ week resistance training 5-10 exercises involving major muscles of leg and foot 3-4 sets per exercise and 10- 15 repetition per set

OTHERhigh intensity laser therapy

905 nm super pulsed laser 40 minute session 3 days /week 150 minutes/ week resistance training 5-10 exercises involving major muscles of leg and foot 3-4 sets per exercise and 10- 15 repetition per set

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients with type 2 diabetes. * Diabetic Patients of age 50 to 75 years. * Diabetic patient of Both genders * Diagnosed Diabetes Mellitus with at least 7 years of duration * Distal symmetrical or asymmetrical polyneuropathy with pain in the lower extremity for ≥6 months * DNS (Diabetic neuropathy symptoms questionnaire) score greater than 4 (90 percent probability of neuropath

Exclusion criteria

* Pregnant females * Lower limb Amputated patients * History or evidence of neurological disorders other than peripheral neuropathy associated with Diabetes mellitus. * Evidence of musculoskeletal dysfunctions like scoliosis, lumbar disc prolapses and lumbar spine associated radiculopathy. * History of any low back surgeries and lower limb surgeries * Patient with malignancy. Patient with epilepsy * Patient with hemophilia * Patient with pacemaker, metal implants prosthesis and internal fixation screws. * Patient with severe cervical and lumbar neuropathy, rheumatoid arthritis, hereditary neuropathy * Patient with a history of neurosurgery

Design outcomes

Primary

MeasureTime frameDescription
michigan neuropathy screening instrument8th weekMNSI is designed to screen for the presence of diabetic neuropathy the first part consist of 15 self administered questions on foot sensations ,pain ,numbness etc second part is brief physical examination of feet
foot and ankle disability index8th weekFADI is designed to assess functional limitations related to foot and ankle conditions it has 26 items each item scored from 0 -4 FADI has totel 104 points

Countries

Pakistan

Contacts

Primary ContactImran Amjad, Phd
Imran.amjad@riphah.edu.pk03324390125

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026